Westwood Holdings Group Inc Crinetics Pharmaceuticals, Inc. Transaction History

Westwood Holdings Group Inc

  • $11.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$15.31 - $21.1 $46,404 - $63,954
3,031 Added 11.95%
28,402 $456,000
Q4 2022

Feb 14, 2023
BUY
$15.49 - $19.05 $67,056 - $82,467
4,329 Added 20.57%
25,371 $464,000
Q3 2022

Nov 14, 2022
BUY
$18.11 - $22.37 $381,070 - $470,709
21,042 New
21,042 $413,000

Others Institutions Holding CRNX

# of Institutions
244
Shares Held
78.2M
Call Options Held
268K
Put Options Held
197K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.73B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Westwood Holdings Group Inc Portfolio

Follow Westwood Holdings Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email